UDAIPUR, India, Sept. 11, 2025 /PRNewswire/ — Hindustan Zinc Limited, the world’s largest integrated zinc producer, has become the first Indian company to join the International Council on Mining and Metals (ICMM) which creates a landmark that positions India on the global map of responsible mining.

Hindustan Zinc Joins Global Leaders in ICMM, Advancing Sustainable Mining Practices

ICMM brings together 25 of the world’s leading mining and metals companies committed to advancing sustainable development, transparency, and ethical practices. Hindustan Zinc’s admission followed a rigorous independent assessment and endorsement by ICMM’s Council, based on recommendations from the Independent Expert Review Panel. This marks ICMM’s first new member since 2021.

By joining, Hindustan Zinc commits to ICMM’s 40 performance expectations covering Environmental, Social, and Governance (ESG) standards, subject to third-party validation across all assets. Membership reinforces the company’s sustainability leadership and enables collaboration with global peers on climate action, biodiversity, circular economy, and inclusion.

Commenting on the development, Arun Misra, CEO & Whole-time Director, Hindustan Zinc said, “It is both an honor and a big responsibility for Hindustan Zinc to become the first Indian company to join ICMM. This milestone marks a new chapter in our Sustainability 2.0 journey, grounded in transparency, innovation and global best practices. For us, sustainability and good business go hand in hand, and it is a strategic imperative to create lasting positive impact on our environment, our communities, and the industry at large. As we integrate ICMM’s principles across every facet of our operations, we look forward to sharing our insights and gaining perspectives from global peers, contributing to a safer, more responsible future for mining worldwide and the planet.”

Welcoming Hindustan Zinc, Rohitesh Dhawan, President & CEO, ICMM said, “We are pleased to welcome Hindustan Zinc as ICMM’s first Indian member. Their inclusion strengthens our collective commitment to responsible mining and reflects the growing importance of India in the global metals and mining industry. Hindustan Zinc’s leadership in sustainability will add valuable perspectives to our work as we shape a safer and more sustainable future for mining.”

Hindustan Zinc has been recognized globally for its ESG leadership. In 2024, it was ranked the world’s most sustainable metals and mining company by the S&P Global Corporate Sustainability Assessment for the second consecutive year. The company has adopted ambitious 2030 Sustainable Goals, validated Science Based Targets aligned to 1.5°C and is committed to achieving net zero by 2050 or sooner.

Media Contact:

Maitreyee Sankhla
Maitreyee.Sankhla@vedanta.co.in 

Driving the Commercialization of Acoustic Technology in Smart Health Wearables through Solution-Based Service Delivery

BEIJING, Sept. 11, 2025 /PRNewswire/ — Datasea Inc. (NASDAQ: DTSS), a Nevada-based technology company specializing in acoustic high-tech products and AI multimodal digital solutions, today announced that its VIE entity in China, Shuhai Jingwei (Shenzhen) Information Technology Co., Ltd., has signed a service agreement with Hainan Zhixingjian Intelligent Technology Co., Ltd.( “Hainan Zhixingjian”). The two companies will collaborate on the commercialization of acoustic smart health shoes.

Agreement Overview

According to the agreement:

• Contract Term: 12 months
• Technology Output: Datasea will provide proprietary acoustic health hardware and software technology solutions for both adult and children’s smart health insoles. This solution integrates Datasea’s acoustic technology into consumer-grade health wearables, enabling functions such as heating, weight monitoring, ultrasonic sterilization to remove odors, as well as relieving fatigue, improving sleep quality, assisting in the treatment of chronic diseases (such as joint pain), and promoting metabolism, among other key benefits.
• Technology Service Fee: The agreement adopts a usage-based licensing model, with technology service fees calculated based on the cumulative production quantity of products incorporating Datasea’s acoustic technology. During the contract period, Hainan Zhixingjian will pay Datasea RMB 9 per pair (USD 1.26) of shoes produced, including a RMB 1 per pair (USD 0.14) fee for the mini-program usage. If production exceeds 1 million pairs, the service fee will decrease to RMB 7 per pair (USD 0.98). Additionally, if the production target is not met by July 31, 2026, Hainan Zhixingjian will still need to pay a minimum guaranteed service fee of RMB 500,000 (approximately USD 70,224).
• Contract Amount: Based on projected production, Datasea expects to generate up to RMB 7 million (approximately USD 0.98 million) in technology service fees during the contract period. With the expansion of third-party cooperation channels, the contract value is expected to increase further.

Hainan Zhixingjian Intelligent Technology Co., Ltd. is an innovative company focused on the smart health wearables and sports wellness sector. Leveraging the policy and research resources of the Hainan Free Trade Zone, the company has launched a product portfolio including smart shoes, intelligent wellness devices, and digital health platforms, having shipped over 3 million pairs of smart shoes. With more than 50 patents and software copyrights, and rapid marketization capabilities, Hainan Zhixingjian is becoming a leading company in the domestic smart health wearable industry.

“This agreement marks the first batch of orders for Datasea’s acoustic technology embedded in smart health shoes, and represents an important step in the commercialization of our acoustic technology + AI + application scenarios. We are not only entering the fast-growing health wearable market but also validating our acoustic technology licensing + solution-driven profit model. This is a vivid example of the company’s transformation from hardware sales to high-margin solution-driven growth, and a reflection of the company’s strategic focus,” said Zhixin Liu, CEO of Datasea. “By combining acoustic technology with AI, we are able to provide comprehensive technical empowerment in the health sector and establish a replicable, scalable commercialization path using the usage-based licensing model, ultimately forming a sustainable source of recurring revenue.”

At the same time, this cooperation also opens new market opportunities for Datasea further expansion of acoustic technology into the healthcare and consumer sector. As a high-frequency consumer wearable, the smart health shoes have natural user stickiness and significant market scalability, driving Datasea’s acoustic technology into the health, medical monitoring, and lifestyle sectors. Building on the company’s research in acoustic + neural modulation, the solution is expected to extend to brain, heart, and foot reflexology for precision health interventions. This partnership not only highlights the company’s R&D and intellectual property advantages in the field of acoustic health, but also echoes the company’s “acoustic + AI + application scenarios” cross-industry empowerment strategy, embedding acoustic technology as the underlying support for products and services across various industries. It further validates the feasibility and forward-looking nature of its cross-industry applications, which will solidify Datasea’s technical barriers and market leadership.

About Datasea Inc.

Datasea Inc. (“Datasea”) is a leading provider of products, services, and solutions for enterprise and retail customers in two innovative industries, acoustic high tech and 5G-AI multimodal digitalization. The Company’s advanced R&D technology serves as the core infrastructure and backbone for its products. Its 5G multimodal digital segment operates on a cloud platform based on AI. Datasea leverages cutting-edge technologies, precision manufacturing, and ultrasonic, infrasound and directional sound technology in its acoustics business to combat viruses and prevent human infections, and it is also developing applications in medical ultrasonic cosmetology. In July 2023, Datasea established a wholly-owned subsidiary, Datasea Acoustics LLC, in Delaware, in a strategic move to enter the U.S. markets and to mark its global expansion plan. For additional information, please visit www.dataseainc.com.

Cautionary Note Regarding Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates”, “target”, “going forward”, “outlook,” “objective” and similar terms. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond Datasea’s control, which may cause Datasea’s actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to Datasea as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in Datasea’s filings with the SEC, which are available at www.sec.gov. Datasea does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Investor and Media Contact: 

Datasea Investor Relations
Email:  investorrelations@shuhaixinxi.com
                       sunhezhi@shuhaixinxi.com 

Precept Investor Relations LLC
David Rudnick
+1 646-694-8538
david.rudnick@preceptir.com

CHENGDU, China, Sept. 11, 2025 /PRNewswire/ — Recently, LivingPhoenix®Regenerative Technologies Development (Chengdu) Co., Ltd. (hereinafter “LivingPhoenix Technology”) announced that its independently developed POGMENT triple-helix biomimetic collagen has, for the first time in the world, achieved high-resolution, molecular-level visualization of “collagen fiber bundles” under near-physiological and ultra-low temperature conditions using Cryo-Electron Microscopy (Cryo-EM). This achievement fills an international gap in the structural understanding of collagen fiber self-assembly mechanisms.

POGMENT is recognized as the world’s first triple-helix biomimetic collagen to overcome the challenge of thermal instability. Its production does not rely on animal tissue extraction, classifying it as a fully synthetic collagen material. This innovation addresses the structural and performance limitations traditionally encountered by animal-derived and recombinant collagens. LivingPhoenix Technology’s founder, Qin Xingjiong, stated that the product has filed multiple international and domestic invention patents, has been registered as a patent-intensive product in China, and has already reached factory-scale production—offering a viable collagen alternative for high-end medical aesthetics and regenerative medicine.

Based on Four Chengdu-Based Invention Patents
Providing a Scientific Structural Basis for the Industry

Collagen, the body’s most abundant and widely distributed functional protein, is often referred to as the “scaffolding of life” due to its essential role in supporting skin, bones, and blood vessels. Today’s market primarily offers animal-extracted collagen, recombinant collagen, and biomimetic collagen, with POGMENT belonging to the latter category.

However, as Qin explained, although the importance of collagen has long been recognized in the scientific community, direct high-resolution imaging evidence of the self-assembly process of collagen monomers into functional “collagen fiber bundles” has been lacking—a gap that has impeded further industrial development.

A Chinese research team has now. In collaboration with the Tianfu Jincheng Laboratory (Frontier Medical Center) Cryo-EM platform team, researchers successfully captured the ultrafine structure of self-assembled “collagen fiber bundles” across multiple batches of POGMENT biomimetic collagen products using a 300kV Cryo-Transmission Electron Microscope (Titan Krios G4).

In addition, using a 120kV room-temperature TEM (Talos L120C) alongside negative staining methods, the research team observed numerous batches of samples to reveal distinctive morphological features of the collagen protein. This marks the world’s first instance of high-resolution imaging at the fiber bundle level for collagen, substantiating its natural-like self-assembly ability while unveiling the structural basis underpinning its role as an “active scaffold.” This achievement fills an international gap in the structural comprehension of collagen fiber assembly mechanisms.

The breakthrough is grounded in four invention patents pre-approved by the Chengdu Patent Protection Center: material invention patents ZL202510440051.4, ZL202510440054.8, ZL202410309842.9, and a use invention patent ZL202510391971.1.

“This accomplishment is not only a technical leap in materials science, but also demonstrates China’s original capabilities and strategic depth in the field of biomedical materials,” said Qin Xingjiong. “It lays a solid foundation for the subsequent functional design, industrial conversion, and clinical application of collagen, while providing essential structural scientific evidence for tissue regeneration, aesthetic medicine, anti-aging treatments, and chronic wound repair.”

The product has reached mass production at the factory level,
enabling broad application across multiple scenarios.

POGMENT’s technological evolution is a microcosm of China’s high-end biomedical material innovation. According to Qin, the technology originated from the initial synthetic collagen work (1.0) developed by a Kyoto University research team. Later, through the incorporation of core processes by Dr. Takafumi Takebayashi (version 1.1) and subsequent collaborative R&D between Chinese and Japanese teams, it was successfully localized in Chengdu Tianfu International Bio-Town (version 1.2), representing a crucial transformation and iteration of key technologies in China.

Ultimately, the second-generation independent intellectual property system (version 2.0) was developed by a team of doctoral researchers from the University of Tokyo, Peking University, the Chinese Academy of Sciences, University Paris Dauphine, and other institutions both in China and abroad.

The technology has filed six Chinese invention patents and six PCT international patent applications. To date, it has been granted three substance patents and patent by the China National Intellectual Property Administration, and has completed China’s patent-intensive product certification. Additionally, multiple trademarks and other intellectual property rights have been successfully registered in the United States, the European Union, the United Kingdom, South Korea, and Japan.

Original research co-authored by LivingPhoenix, the Ninth People’s Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Beijing Hospital National Center for Gerontology, Peking University Third Hospital, and the University of Tokyo, among other institutions, has passed peer review and was published in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology (Impact Factor: 4.8). These milestones mark the technology’s entry into a high-standard, high-barrier phase of development.

The project has achieved factory-level mass production. Its unit cost is comparable to that of recombinant collagen, and with the launch of an intelligent factory and further production scale expansion, the annual solution capacity is expected to reach 30 tons. Costs are anticipated to drop to 50% of that of the current recombinant collagen, positioning the product as a high-performance, cost-effective alternative for high-end medical aesthetics and regenerative medicine.

According to research by Head Leopard Research Institute under Frost & Sullivan, China’s biomimetic collagen market is predicted to surge from less than one million yuan in 2025 to 6.778 billion yuan in 2030, with a compound annual growth rate exceeding 150%. Leveraging its structural advantages, POGMENT biomimetic collagen has been officially incorporated into China’s medical industry standard Terminology for Collagen in Tissue-Engineered Medical Devices (YY/T1955-2025), issued by the National Medical Products Administration (NMPA). It has also completed registration in the Medical Device Master File system under the Center for Medical Device Evaluation (CMDE) of the NMPA.

Furthermore, LivingPhoenix Technology has established a classification catalog for injectable freeze-dried biomimetic collagen fibers—covering multiple application scenarios. The product has achieved cross-domain application approval as a Class III medical device and shows potential as a raw material for cosmetics.

For further information on application opportunities in functional cosmetics, medical aesthetics, tissue engineering, or high-end biomedical materials, please contact LivingPhoenix Technology’s official team at:
POGMENT@mylivingphoenix.com 
Official website: www.mylivingphoenix.com

BERLIN, Sept. 11, 2025 /PRNewswire/ — At the 2025 IFA (Internationale Funkausstellung Berlin) in Germany, the debut of Dreame’s world-first dual robotic arm air conditioner X-Wind series, which is awarded the “Technology Innovation Award” by the China Household Electric Appliance Research Institute (CHEARI), has caused a sensation, making Dreame one of the most anticipated brands.

X-Wind series has achieved a breakthrough in “active airflow” with the world’s first dual robotic arm airflow technology. Based on 126° ultra-wide-angle airflow technology, FlexEngine™ millimeter-level control system and deep AI algorithms, X-Wind intelligently switches the wind sensation, providing users with a personalized, comfortable experience. The jury from CHEARI believes that this technology represents the innovative strength of Chinese home appliance brands.

During the exhibition, Dreame’s booth was bustling with people, with many visitors queuing up to experience its intelligent airflow. European dealers said that the zoned airflow and anti-direct blowing design of this air conditioner well meet the high comfort requirement of local families.

Dreame’s robotic arm air conditioner has received extensive attention from international technology media. Journalists and creators from many countries have given positive evaluations of its innovative technology. Chinese media also believe that this foreign debut is a demonstration of Chinese brands’ global innovation power.

IFA is the start of the global push of Dreame Dual Robotic Arm Air Conditioner. Relying on technological accumulation in the field of intelligent robot, Dreame has deeply integrated aerospace-grade algorithms with mechanical design. In the future, it will continue to expand the application of robotic arm technology in the field of air control, providing global users with smarter, healthier air solutions.

Reported by Shuzhi Society.

Ten-year alliance leverages Infosys AI-first platforms to drive innovation, efficiency and agility across HanesBrands’ IT Landscape

BENGALURU, India, Sept. 11, 2025 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced a strategic alliance with HanesBrands Inc. (NYSE: HBI), a global leader in everyday iconic apparel. Under this ten-year engagement, Infosys will serve as HanesBrands’ strategic collaborator in their digital, business applications and data landscape.

As part of this collaboration, Infosys will deploy its proprietary platforms—Live Enterprise Automation Platform (LEAP), integrated within Infosys Topaz, an AI-first suite of services, solutions, and platforms. This initiative will harness generative AI and AIOps technologies to help HanesBrands modernize core operations, enhance agility, simplify its IT landscape and unlock greater value from data.

The alliance reflects a strong cultural alignment between Infosys and HanesBrands, grounded in a shared vision for innovation and operational excellence. By embracing AI-first technologies, intelligent automation and AIOps, HanesBrands is positioned to unlock hyper productivity, reduce operational complexity and accelerate its digital transformation.

Scott Pleiman, Chief Strategy, Transformation, Analytics and Technology Officer, HanesBrands, said, “As we continue to evolve our operational model, we sought an experienced collaborator with deep domain expertise and advanced capabilities in AI-driven transformation. Infosys’ AI-first approach and proven ability to scale innovation aligned with our long-term vision for agility, efficiency and customer-centricity.”

Karmesh Vaswani, EVP & Global Head, Consumer, Retail & Logistics, Infosys, said, “We are honored to support HanesBrands in its journey toward a future-ready enterprise. With a shared commitment to innovation, we aim to unlock significant business value and elevate customer experiences utilizing Infosys Topaz AI and AIOps capabilities, now further strengthened with LEAP.”

Through this initiative, HanesBrands will address key strategic priorities including technology optimization, resource efficiency and cultural alignment—empowered by Infosys’ robust transformation capabilities and proven track record in the retail sector.

About HanesBrands Inc.

HanesBrands (NYSE: HBI), the No. 1 seller of innerwear, is a socially responsible global leader in everyday iconic apparel with a mission to create a more comfortable world for everybody. The company owns a portfolio of some of the world’s most recognized apparel brands including Hanes, the leading basic apparel brand in the U.S.; Bonds, an Australian staple since 1915 that is setting new standards for design and innovation; Maidenform, America’s number one shapewear brand; and Bali, America’s number one national bra brand. HanesBrands owns the majority of its worldwide manufacturing facilities and has built a strong reputation for workplace quality, ethical business practices, and reducing environmental impact.

About Infosys

Infosys is a global leader in next-generation digital services and consulting. Over 320,000 of our people work to amplify human potential and create the next opportunity for people, businesses, and communities. We enable clients in more than 59 countries to navigate their digital transformation. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer clients, as they navigate their digital transformation powered by cloud and AI. We enable them with an AI-first core, empower the business with agile digital at scale and drive continuous improvement with always-on learning through the transfer of digital skills, expertise, and ideas from our innovation ecosystem. We are deeply committed to being a well-governed, environmentally sustainable organization where diverse talent thrives in an inclusive workplace.

Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.

Safe Harbor

Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, increased competition for talent, our ability to attract and retain personnel, increase in wages, investments to reskill our employees, our ability to effectively implement a hybrid work model, economic uncertainties and geo-political situations, technological disruptions and innovations such as artificial intelligence (“AI”), generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2025. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.